A detailed history of Vontobel Holding Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 14,590 shares of NBIX stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,590
Previous 12,951 12.66%
Holding current value
$1.83 Million
Previous $1.78 Million 5.78%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$114.58 - $153.15 $187,796 - $251,012
1,639 Added 12.66%
14,590 $1.68 Million
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $628,258 - $687,455
4,801 Added 58.91%
12,951 $1.78 Million
Q1 2024

May 10, 2024

BUY
$130.4 - $143.74 $76,414 - $84,231
586 Added 7.75%
8,150 $1.12 Million
Q4 2023

Jun 03, 2024

SELL
$106.07 - $132.76 $251,279 - $314,508
-2,369 Reduced 28.01%
6,089 $802,000
Q4 2023

Jan 29, 2024

SELL
$106.07 - $132.76 $277,585 - $347,432
-2,617 Reduced 25.7%
7,564 $996,000
Q3 2023

Jun 03, 2024

SELL
$94.02 - $117.1 $117,525 - $146,375
-1,250 Reduced 12.88%
8,458 $951,000
Q3 2023

Oct 10, 2023

SELL
$94.02 - $117.1 $117,525 - $146,375
-1,250 Reduced 10.94%
10,181 $1.15 Million
Q2 2023

Jun 03, 2024

SELL
$89.53 - $104.87 $53,270 - $62,397
-595 Reduced 5.78%
9,708 $915,000
Q2 2023

Jul 24, 2023

SELL
$89.53 - $104.87 $53,270 - $62,397
-595 Reduced 4.95%
11,431 $1.08 Million
Q1 2023

Jun 03, 2024

BUY
$94.11 - $123.02 $202,618 - $264,862
2,153 Added 26.42%
10,303 $1.04 Million
Q1 2023

Apr 12, 2023

BUY
$94.11 - $123.02 $828,638 - $1.08 Million
8,805 Added 273.36%
12,026 $1.22 Million
Q4 2022

Feb 14, 2023

SELL
$106.72 - $127.06 $282,167 - $335,946
-2,644 Reduced 45.08%
3,221 $384,000
Q3 2022

Nov 04, 2022

BUY
$92.03 - $107.81 $88,256 - $103,389
959 Added 19.55%
5,865 $603,000
Q2 2022

Jul 27, 2022

SELL
$75.79 - $100.07 $2.67 Million - $3.52 Million
-35,189 Reduced 87.76%
4,906 $482,000
Q1 2022

May 13, 2022

BUY
$72.45 - $94.81 $1.32 Million - $1.73 Million
18,222 Added 83.31%
40,095 $3.71 Million
Q4 2021

Feb 14, 2022

BUY
$79.65 - $106.22 $309,838 - $413,195
3,890 Added 21.63%
21,873 $1.85 Million
Q3 2021

Oct 29, 2021

SELL
$86.18 - $99.03 $119,445 - $137,255
-1,386 Reduced 7.16%
17,983 $1.72 Million
Q2 2021

Aug 06, 2021

BUY
$89.43 - $102.27 $301,736 - $345,058
3,374 Added 21.09%
19,369 $1.88 Million
Q1 2021

May 11, 2021

SELL
$87.57 - $119.4 $250,275 - $341,245
-2,858 Reduced 15.16%
15,995 $1.56 Million
Q4 2020

Feb 12, 2021

BUY
$86.91 - $108.33 $1.64 Million - $2.04 Million
18,853 New
18,853 $2.22 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.